Opinion: GM Salmon: Just the Beginning

Sound risk management concerning genetically engineered food animals is critical.

Written byDarek Moreau
| 4 min read

Register for free to listen to this article
Listen with Speechify
0:00
4:00
Share

WIKIMEDIA, NOAAResearch and development into genetically modified (GM) or genetically engineered (GE) animals for food production is arguably one of the most controversial scientific topics capturing the public’s attention these days. Even a cursory scan of popular media on the topic would suggest an ongoing, highly polarized debate about the impact GE animal biotechnologies stand to have on the world.

In one corner, the pro-GE camp maintains that such biotechnologies will only provide positive benefits to society. This group suggests that GE animals can save both producers and consumers money, provide more nutritious animal food products, provide better access to such nutritious products, and increase the health and wellbeing of the animals used in food production. Ostensibly, the pro-GE camp views genetic biotechnologies as continuing the long legacy of scientific innovation enriching the human experience.

Opposing this view is the anti-GE camp, which maintains that the fusion of corporate self-interest and irresponsible scientific acumen could be a recipe for unintended negative consequences. This group suggests that there are potentially serious environmental and human health risks associated with GE animals that are not being taken seriously. ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Share
Illustration of a developing fetus surrounded by a clear fluid with a subtle yellow tinge, representing amniotic fluid.
January 2026

What Is the Amniotic Fluid Composed of?

The liquid world of fetal development provides a rich source of nutrition and protection tailored to meet the needs of the growing fetus.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies

Parse Logo

Parse Biosciences and Graph Therapeutics Partner to Build Large Functional Immune Perturbation Atlas

Sino Biological Logo

Sino Biological's Launch of SwiftFluo® TR-FRET Kits Pioneers a New Era in High-Throughout Kinase Inhibitor Screening

SPT Labtech Logo

SPT Labtech enables automated Twist Bioscience NGS library preparation workflows on SPT's firefly platform